Prostate Cancer Foundation

Genetic testing looks for variations in a person’s genes. Finding gene variations can help with decisions about cancer treatment. Finding gene variations can also help to understand why cancer developed and how best to find cancers early or to prevent them altogether.

Across the U.S., Black men are disproportionally diagnosed with prostate cancer and are more likely to die from the disease than their white counterparts.

VA teamed up with the Prostate Cancer Foundation (PCF) to encourage men (and their families) to better understand prostate cancer risk and taking proactive measures to protect their health.

VA is a leader in medical research that helps Veterans and all Americans. We're also part of the national research effort to find treatments for COVID-19.

VA researchers will be testing the prostate cancer drug degarelix for treating nearly 200 COVID-19 patients at VA medical centers.

Hear the latest on treating prostate cancer. Check out a Feb. 24 lecture, online or in person at VA headquarters, on precision oncology for Veterans.

A partnership between VA and the Prostate Cancer Foundation is speeding the development of treatments and cures for Veterans with aggressive—or metastatic—prostate cancer through precision oncology.